Atlas Trials

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Clinical trial NCT06367517 · COMPLETED

Trial details

NCT number
NCT06367517
Sponsor
Medical University of Warsaw
Status
COMPLETED
Study type
OBSERVATIONAL
Orbitopathy, GravesThyroid Eye DiseaseOphthalmopathy
Start date
2021-05-20
Primary completion
2025-05-20
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.